Graf Akcie CTSO (Cytosorbents Corp). Diskuze k akciím CTSO. Aktuální informace CTSO.

Základní informace o společnosti Cytosorbents Corp (Akcie CTSO)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 262.13M
Hodnota podniku (EV) N/A
Tržby 45.125M
EBITDA N/A
Zisk -10.36
Růst v tržbách Q/Q 22.76 %
Růst v tržbách Y/Y 40.90 %
P/E (Cena vůči ziskům) 0.00
Forward P/E 23.77
EV/Sales 6.53
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 5.81
P/FCF N/A
Price/Book 3.31
Účetní hodnota na akcii 1.81
Hotovost na akcii 1.63
FCF vůči ceně -3.94 %
Počet zaměstnanců 195
Tržba na zaměstnance 231.412k
Profit margin -19.11 %
Operating margin -27.41 %
Gross margin 73.05 %
EBIT margin -24.09 %
EBITDA margin -50.42 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 37.50 %
EPS - Očekávaný růst příští rok 350.00 %
Return on assets -10.91 %
Return on equity -13.32 %
ROIC -13.23 %
ROCE -12.44 %
Dluhy/Equity 0.14
Čistý dluh/EBITDA 5.36
Current ratio 7.14
Quick Ratio 6.80
Volatilita 5.80
Beta 0.59
RSI 16.21
Cílová cena analytiků 15
Známka akcie (dle analytiků) 1.00
Insider ownership 8.46 %
Institutional ownership 43.50 %
Počet akcií 43.369M
Procento shortovaných akcií 4.57 %
Short ratio 7.32 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2006
Země United States

Finanční výsledky akcie CTSO

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$24.95$22.504$15.151$9.528$4.792$4.123
Cost Of Goods Sold$7.364$7.489$5.518$3.954$2.213$2.134
Gross Profit$17.586$15.015$9.632$5.574$2.579$1.989
Research And Development Expenses$12.092$7.723$3.221$4.073$3.871$2.432
SG&A Expenses$22.006$20.874$14.914$11.808$6.923$5.553
Other Operating Income Or Expenses$-2.462$-2.002$-1.34$-1.185$-1.089$-0.897
Operating Expenses$43.924$38.089$24.993$21.02$14.095$11.016
Operating Income$-18.974$-15.585$-9.843$-11.492$-9.304$-6.893
Total Non-Operating Income/Expense$-1.384$-2.246$0.705$-0.59$-0.498$-2.815
Pre-Tax Income$-20.358$-17.831$-9.138$-12.082$-9.802$-9.707
Income Taxes$-1.092$-0.62$-0.677$-0.319$-0.325$-0.386
Income After Taxes$-19.266$-17.211$-8.461$-11.764$-9.477$-9.322
Other Income------
Income From Continuous Operations$-19.266$-17.211$-8.461$-11.764$-9.477$-9.322
Income From Discontinued Operations------
Net Income$-19.266$-17.211$-8.797$-11.764$-9.477$-18.588
EBITDA$-18.277$-15.097$-9.542$-11.3$-9.191$-6.629
EBIT$-18.974$-15.585$-9.843$-11.492$-9.304$-6.893
Basic Shares Outstanding323128252514
Shares Outstanding323128252514
Basic EPS$-0.60$-0.56$-0.32$-0.46$-0.38$-1.29
EPS - Earnings Per Share$-0.60$-0.56$-0.32$-0.46$-0.38$-1.29
# 2020 2019 2018 2017 2016 2015
Current Ratio2.10364.08632.64251.82993.23951.6884
Long-term Debt / Capital0.79660.35390.36860.753--
Debt/Equity Ratio4.40370.5870.97363.6724--
Gross Margin70.484766.719663.57758.503553.824648.2421
Operating Margin-76.05-69.2543-64.9644-120.6162-194.1654-167.1872
EBIT Margin-76.05-69.2543-64.9644-120.6162-194.1654-167.1872
EBITDA Margin-73.2574-67.0876-62.9822-118.6001-191.8077-160.7792
Pre-Tax Profit Margin-81.5973-79.2339-60.3108-126.8074-204.558-235.453
Net Profit Margin-77.2186-76.4809-58.06-123.464-197.7835-450.8643
Asset Turnover0.91110.65810.62860.98290.42580.4868
Inventory Turnover Ratio3.48368.98946.93564.74081.85823.9695
Receiveable Turnover5.58525.70716.86846.64677.38465.033
Days Sales In Receivables65.351663.95553.141854.914449.427472.5207
ROE - Return On Equity-563.6439-101.6332-82.4411-879.5433-115.4248-235.2072
Return On Tangible Equity-563.6458-101.6332-82.4412-879.538-115.4245-235.2067
ROA - Return On Assets-70.3575-50.3299-35.1022-121.3498-84.2076-110.073
ROI - Return On Investment-114.6521-65.6686-52.0505-217.2073-115.4245-235.2067
Book Value Per Share0.10480.5330.35420.05250.32330.1701
Operating Cash Flow Per Share-0.1667-0.11890.03060.0990.0731-0.0671
Free Cash Flow Per Share-0.1665-0.10490.00040.10960.0675-0.0736